A 10-Year Single-Center Experience With the GORE TAG Conformable Thoracic Stent Graft in the Treatment of Thoracic Aortic Disease.
Denis SkrypnikMoritz S BischoffKatrin MeisenbacherDorothea B KronsteinerDittmar BöcklerPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2021)
The herein reported 10-year real-world single-center experience with the CTAG observed favorable long-term outcome. Thus, the device demonstrates appropriate persistent safety, efficacy, and clinical durability up to long-term FU in the treatment of diverse thoracic aortic pathologies.